Schobel Alexander Mark 4
4 · Aquestive Therapeutics, Inc. · Filed Jul 2, 2020
Insider Transaction Report
Form 4
Schobel Alexander Mark
Chief Innovation/Tech Officer
Transactions
- Tax Payment
Common Stock
2020-06-30$4.86/sh−94$457→ 912,792 total - Exercise/Conversion
Restricted Stock Units
2020-06-30−333→ 0 totalExercise: $0.00From: 2020-06-30→ Common Stock (333 underlying) - Exercise/Conversion
Common Stock
2020-06-30+333→ 912,886 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award. The amount retained by the Company was not in excess of the amount of the tax liability.
- [F3]There are no expiration dates on RSUs.